Q&A With Mark McDonough, CEO of ChromaCode


Medical Device & Technology

ChromaCode recently announced that it teamed up with MedGenome to expand its HD PCR technology to India and the Middle East. Mark McDonough, CEO of the genomics multiplexing platform company, spoke with MDT about the HD PCR technology and the benefits of the recent expansion.

(MDT:) How does ChromaCode’s HD PCR tech work?

McDonough: ChromaCode is a company that was incubated out of Caltech. Our founder was at the Caltech and then Google on the genomic side. When you think about HD PCR technology, the thing that really encapsulates it is that it’s high definition PCR, so we’re combining the power of PCR with the ChromaCode cloud.

View full article

More Articles Here